Chuang Yue - Search Results

Year	Number of Results
2012	1
2013	3
2014	2
2015	1
2016	2
2018	1
2019	4
2020	3
2021	5
2022	2
2023	1
2024	1

1

Three-Dimensional Self-Supported Ge Anode for Advanced Lithium-Ion Batteries.

Fang XX, Jiang C, Yue C, Hu F. Fang XX, et al. Among authors: yue c. Chemistry. 2024 Mar 4:e202400063. doi: 10.1002/chem.202400063. Online ahead of print. Chemistry. 2024. PMID: 38436136 Review.

2

RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma.

Zhu D, Zhang L, Shi X, Gao S, Yue C, Zhang L, Bai YU, Wang Q, Okada A, Yasui T, Wang C, Cui X, Zuo LI. Zhu D, et al. Among authors: yue c. Oncol Res. 2022 Aug 1;29(3):159-174. doi: 10.32604/or.2022.03458. eCollection 2021. Oncol Res. 2022. PMID: 37304674 Free PMC article.

3

Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.

Shi X, Peng X, Chen Y, Shi Z, Yue C, Zuo L, Zhang L, Gao S. Shi X, et al. Among authors: yue c. Front Immunol. 2023 Dec 7;14:1326509. doi: 10.3389/fimmu.2023.1326509. eCollection 2023. Front Immunol. 2023. PMID: 38130721 Free PMC article.

4

A Standardized Step-by-Step Approach for the Diagnosis and Treatment of Sepsis.

Gao Y, Wang HL, Zhang ZJ, Pan CK, Wang Y, Zhu YC, Xie FJ, Han QY, Zheng JB, Dai QQ, Ji YY, Du X, Chen PF, Yue CS, Wu JH, Kang K, Yu KJ. Gao Y, et al. Among authors: yue cs. J Intensive Care Med. 2022 Oct;37(10):1281-1287. doi: 10.1177/08850666221085181. Epub 2022 Mar 14. J Intensive Care Med. 2022. PMID: 35285730

5

Integrative analysis the characterization of peroxiredoxins in pan-cancer.

Gao L, Meng J, Yue C, Wu X, Su Q, Wu H, Zhang Z, Yu Q, Gao S, Fan S, Zuo L. Gao L, et al. Among authors: yue c. Cancer Cell Int. 2021 Jul 10;21(1):366. doi: 10.1186/s12935-021-02064-x. Cancer Cell Int. 2021. PMID: 34246267 Free PMC article.

6

Association between SOD2 V16A variant and urological cancer risk.

Zhang LF, Xu K, Tang BW, Zhang W, Yuan W, Yue C, Shi L, Mi YY, Zuo L, Zhu LJ. Zhang LF, et al. Among authors: yue c. Aging (Albany NY). 2020 Jan 12;12(1):825-843. doi: 10.18632/aging.102658. Epub 2020 Jan 12. Aging (Albany NY). 2020. PMID: 31929112 Free PMC article.

7

The association between three AXIN2 variants and cancer risk.

Dai F, Zhu LJ, Zhang W, Mi YY, Sun HY, Zhang LF, Yue C, Wu XY, Zuo L, Bai Y. Dai F, et al. Among authors: yue c. J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30. J Cell Biochem. 2019. PMID: 31038806

8

The oncogenic role of MUC12 in RCC progression depends on c-Jun/TGF-β signalling.

Gao SL, Yin R, Zhang LF, Wang SM, Chen JS, Wu XY, Yue C, Zuo L, Tang M. Gao SL, et al. Among authors: yue c. J Cell Mol Med. 2020 Aug;24(15):8789-8802. doi: 10.1111/jcmm.15515. Epub 2020 Jun 28. J Cell Mol Med. 2020. PMID: 32596961 Free PMC article.

9

Association between three genetic variants in kallikrein 3 and prostate cancer risk.

Ding WH, Ren KW, Yue C, Zou JG, Zuo L, Zhang LF, Bai Y, Okada A, Yasui T, Mi YY. Ding WH, et al. Among authors: yue c. Biosci Rep. 2018 Nov 30;38(6):BSR20181151. doi: 10.1042/BSR20181151. Print 2018 Dec 21. Biosci Rep. 2018. PMID: 30413614 Free PMC article.

10

CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.

Zhu L, Wang J, Yue C, Yuan W, Zhang W, Shi L, Mi Y, Wu X, Zhang LF, Zuo L. Zhu L, et al. Among authors: yue c. J Cell Biochem. 2019 Oct;120(10):18346-18356. doi: 10.1002/jcb.29144. Epub 2019 Jun 30. J Cell Biochem. 2019. PMID: 31257659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year